---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017814"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:28:23.913207+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions amends CEO & CFO employment agreements, raises salaries

## Summary
- CEO salary increased from AUD 560,000 to AUD 580,000; CFO from AUD 410,000 to AUD 430,000, effective June 30, 2025.
- Enhanced severance: on termination without cause, 100% bonus and full equity vesting; after Change in Control adds 2x salary.
- Non-compete revised to tiered restricted period (24 to 1 month) and broadened scope to prohibit any interest in competing entities.
- Change in Control defined as acquisition of >20% voting stock, certain mergers, asset sale, or Board composition change, excluding stock repurchases.

## SEC filing metadata
- accession: 0001641172-25-017814
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000164117225017814/0001641172-25-017814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000164117225017814/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017814
- JSON: https://secwatch.observer/filing/0001641172-25-017814.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017814.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.